Robbins LLP has initiated a class action lawsuit against Agilon Health, Inc. (AGL), targeting investors who purchased the company's securities during a six-month period from February 26, 2025 through August 4, 2025. The lawsuit alleges that Agilon issued forward-looking guidance for 2025 that was not achievable given known headwinds in the healthcare industry, while simultaneously overstating the positive effects of its strategic risk reduction initiatives.
The litigation follows a significant deterioration in Agilon's stock price, which declined more than 50 percent following the company's announcement of disappointing financial results on August 4, 2025. The announcement also coincided with the departure of the company's chief executive officer. These events have prompted the law firm to seek plaintiffs who sustained substantial losses during the relevant period.
Investors who held AGL securities during the class period and experienced material losses are being encouraged to contact Robbins LLP regarding potential involvement in the case. The firm is accepting nominations for lead plaintiff positions, with a deadline of March 2, 2026 for interested parties to submit their claims.